Seres Therapeutics Enters Into Memorandum of Understanding For Vowst™ Asset Sale to Nestlé Health Science
June 06, 2024 06:30 ET | Seres Therapeutics, Inc.
Seres anticipates capital infusions, including an upfront payment, enabling the Company to fully retire its debt and extend its cash runway into Q4 2025, pending deal closure and subject to...
FR8technologies-logo_v3-09_-__baja_(1)_(1)_(1).jpg
Freight Technologies Adds 26 New Customers and 149 New Carriers in 2024
June 06, 2024 06:30 ET | Freight App, Inc.
Fr8App is proud to announce it has on-boarded 26 new customers and 149 new carriers to its platform year-to-date.
M3+ Delinquency Rate by Vintage
Jiayin Group Inc. Reports First Quarter 2024 Unaudited Financial Results
June 06, 2024 06:00 ET | Jiayin Group Inc.
-- First Quarter Total Loan Facilitation Volume Grew 13.6% to RMB22.5 billion ---- First Quarter Net Revenue Grew 31.5% to RMB1,475.3 million -- SHANGHAI, June 06, 2024 (GLOBE NEWSWIRE) -- Jiayin...
HookerFurnishings.jpg
Hooker Furnishings Reports First Quarter Operating Results and Cost Reduction Plan
June 06, 2024 06:00 ET | Hooker Furnishings Corporation
MARTINSVILLE, Va., June 06, 2024 (GLOBE NEWSWIRE) -- Hooker Furnishings Corporation (NASDAQ-GS: HOFT) (the “Company” or “HFC”), a global leader in the design, production, and marketing of home...
QuantaSing Announces Unaudited Financial Results for the Third Quarter of Fiscal Year 2024
June 06, 2024 05:00 ET | QuantaSing Group Limited
BEIJING, June 06, 2024 (GLOBE NEWSWIRE) -- QuantaSing Group Limited (NASDAQ: QSG) (“QuantaSing” or the “Company”), a leading online learning service provider in China, today announced its unaudited...
Sagimet-Logo-for-light-bg-FIN.png
Sagimet Biosciences Presents Data from ITT and F3 Patient Population in Phase 2b FASCINATE-2 Clinical Trial of Denifanstat at EASL International Liver Congress 2024
June 06, 2024 05:00 ET | Sagimet Biosciences Inc.
Denifanstat achieved statistically significant results on primary and secondary liver biopsy endpoints in the ITT population, including both histology endpoints recommended in the FDA draft guidance...
QuantaSing Announces Changes in Composition of Board and Management
June 06, 2024 04:00 ET | QuantaSing Group Limited
BEIJING, June 06, 2024 (GLOBE NEWSWIRE) -- QuantaSing Group Limited (NASDAQ: QSG) (“QuantaSing” or the “Company”), a leading online learning service provider in China, today announced changes in the...
画板s.png
Aurora Mobile Limited Announces First Quarter 2024 Unaudited Financial Results
June 06, 2024 03:30 ET | Aurora Mobile Limited
SHENZHEN, China, June 06, 2024 (GLOBE NEWSWIRE) -- Aurora Mobile Limited (“Aurora Mobile” or the “Company”) (NASDAQ: JG), a leading provider of customer engagement and marketing technology services...
Olink Proteomics AB.png
Olink® Target 48 Immune Surveillance Panel – The Next Frontier in Immune Biomarker Profiling with Absolute Confidence
June 06, 2024 02:00 ET | Olink Proteomics AB
UPPSALA, Sweden, June 06, 2024 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced the introduction of Olink Target 48 Immune Surveillance, a validated multiplexed protein...
Gauzy Ltd. Announces Pricing of $75 Million Initial Public Offering
June 06, 2024 01:15 ET | GAUZY LTD
Gauzy Ltd. Announces Pricing of $75 Million Initial Public Offering. Shares to Begin Trading on Nasdaq on June 6, 2024.